Chen Lun, Zhu Tong, Qi Jia, Zhang Yufeng, Zhang Zigang, Liu Haitao
Department of Pharmacy, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Department of Pharmacy, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Respiratory, Jiangyin Hospital Affiliated to Nanjing University of Chinese Medicine, Jiangyin, China.
Ann Palliat Med. 2021 Jul;10(7):7486-7513. doi: 10.21037/apm-21-1140.
JiaWeiSiWu granule (JWSWG) has been applied clinically for more than a decade, and the preliminary results show that blood pressure can be reduced while protecting the target organ at the same time. The purpose of this research is to study the pharmacological mechanism of JWSWG in treating hypertension using network pharmacology.
The chief active components, relevant targets, and the target genes of JWSWG were retrieved by the databases TCMSP and UniProt. The GeneCards database was used to obtain target genes of hypertension. Then, the target genes of hypertension and active components were intersected to discover the potential targets by which JWSWG acts on hypertension. Cytoscape software was employed to construct the "medicine-compound-target-disease" network. The STRING database was used to construct the protein-protein interaction network in order to screen the key target genes. Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment were analyzed by RGUI and org.Hs.eg.db.
By intersecting 102 compound target genes with 6,732 target genes of hypertension, 88 action target genes were obtained, thereby screening out the key compounds and key targets. The results of GO enrichment showed the main molecular functions, biological processes, and cellular components. The main pathways of JWSWG in treating hypertension were revealed by KEGG pathway enrichment.
This research clarified the mechanism of JWSWG in the treatment of hypertension systematically, providing new potential ideas and a theoretical foundation for further experimental and clinical research.
加味四物汤颗粒(JWSWG)已临床应用十余年,初步结果表明其在降低血压的同时可保护靶器官。本研究旨在运用网络药理学研究加味四物汤颗粒治疗高血压的药理机制。
通过中药系统药理学数据库与分析平台(TCMSP)和通用蛋白质数据库(UniProt)检索加味四物汤颗粒的主要活性成分、相关靶点及靶基因。利用基因卡片数据库(GeneCards)获取高血压的靶基因。然后,将高血压的靶基因与活性成分进行交集分析,以发现加味四物汤颗粒作用于高血压的潜在靶点。采用Cytoscape软件构建“药物 - 化合物 - 靶点 - 疾病”网络。利用STRING数据库构建蛋白质 - 蛋白质相互作用网络,以筛选关键靶基因。通过RGUI和org.Hs.eg.db分析基因本体(GO)富集和京都基因与基因组百科全书(KEGG)通路富集情况。
通过将102个化合物靶基因与6732个高血压靶基因进行交集分析,获得88个作用靶基因,从而筛选出关键化合物和关键靶点。GO富集结果显示了主要的分子功能、生物学过程和细胞成分。KEGG通路富集揭示了加味四物汤颗粒治疗高血压的主要途径。
本研究系统阐明了加味四物汤颗粒治疗高血压的机制,为进一步的实验和临床研究提供了新的潜在思路和理论基础。